Trials / Completed
CompletedNCT00710203
Dermatosis Papulosa Nigra
Efficacy of a 585 nm Pulsed Dye Laser (PDL) for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulsed dye laser | One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion. |
| PROCEDURE | Curettage | A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference. |
| PROCEDURE | Electrodesiccation | A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine. |
| OTHER | No treatment | A fourth lesion will not be treated and will serve as a control. |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-07-04
- Last updated
- 2015-04-28
- Results posted
- 2014-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00710203. Inclusion in this directory is not an endorsement.